###### What is known about the subject?

-   Accurate measurement of oxygen saturation is important in sickle cell disease (SCD).

-   Discrepancies in oxygen saturation have been shown between pulse oximetry and CO-oximetry on arterial blood samples in children with SCD.

###### What this study adds?

-   In clinically stable children with SCD, pulse oximetry does not accurately reflect haemoglobin saturation, especially at SpO~2~ values ≤93%.

-   In these cases, CO-oximetry on arterialised earlobe blood is an easier to obtain alternative to traditional arterial blood sampling.

Introduction {#s1}
============

Sickle cell disease (SCD) is an inherited disorder of haemoglobin (Hb), characterised by recurrent episodes of acute illness related to red blood cells sickling and subsequent vaso-occlusion.[@R1] Hypoxaemia is a predictor of vaso-occlusive pain[@R2] and may be an early sign of acute chest syndrome (ACS)[@R3]; therefore, accurate measurement of arterial oxygen saturation is important to guide management in both ambulatory and emergency setting.[@R4] The most accurate measure of oxyhaemoglobin is by CO-oximetry on arterial blood (SaO~2~), which is reliable in individuals with either predominant HbA or HbS.[@R5] Minute-by-minute changes of oxygen saturation are detected with non-invasive pulse oximetry (SpO~2~) that shows a good correlation with CO-oximetry in individuals with normal Hb phenotype.[@R7] However, people with SCD represent a different population in which previous small studies have shown some discrepancies between SpO~2~ and SaO~2~ measured by CO-oximetry.[@R8] Treatment decisions in patients with SCD are often influenced by SpO~2~ findings, especially in the acute care setting where inaccuracies can result in misdiagnosis or mismanagement. For example, during an ACS episode, failure to detect hypoxaemia may delay the start of oxygen supplementation, which is a mainstay of supportive therapy.[@R13] On the other hand, underestimation of oxygen saturation by SpO~2~ may lead the clinician to an inappropriate use of oxygen supplementation, with detrimental effects on erythropoiesis.[@R14]

Although arterial gas analysis with CO-oximetry is the gold standard to evaluate oxygen saturation in patients with SCD, the procedure is distressing and poorly tolerated in children. Measuring SaO~2~ by CO-oximetry on arterialised earlobe blood gas (EBG) is an alternative procedure that shows reasonable agreement with traditional arterial blood gas, especially for low arterial PO~2~ values that are more relevant in the clinical setting.[@R15] The use of EBG in patients with SCD is attractive as it allows to reduce discomfort and pain[@R17]: a valuable target in population at risk of psychological complications related to the high burden of pain experienced.[@R18]

This retrospective study sought to investigate the agreement between SpO~2~ and SaO~2~ measured on EBG with CO-oximetry in ambulatory paediatric patients with SCD. We hypothesised that SpO~2~ would not be highly accurate in predicting SaO~2~. Since the presence of acute comorbidity might have affected these measurements, especially for SpO~2~ whose accuracy worsens when SaO~2~ is lower than 90%,[@R19] we limited our analysis to patients who did not have acute symptoms at the time of evaluation.

Methods {#s2}
=======

We retrospectively reviewed our electronic database of patients with SCD aged 5--18 years with respiratory issues attending the paediatric respiratory clinic at King's College Hospital, London, from 1 February 2012 to 1 August 2015. Evaluation of SaO~2~ through EBG with CO-oximetry, in addition to SpO~2~, represents a standard clinical practice in this clinic and it was routinely proposed to the attending patients. Those who accepted to undergo the EBG and had a successful measure of SaO~2~ were included in the analysis. Reasons for referral to the respiratory clinic were mainly asthma symptoms and sleep disordered breathing (eg, loud snoring, witnessed apnoeas, restless sleep and mouth breathing). Participants had simultaneous EBG with CO-oximetry and SpO~2~ measurements taken in room air during their visit. Only patients who had paired and valid EBG and SpO~2~ data taken during the same visit were included in the analysis. None of the subjects enrolled were suffering from SCD-related acute events (eg, painful crises, ACS, etc) at the time of evaluation. Pulse oximetry was performed using a Nonin GO~2~ pulse oximeter (Nonin, Plymouth, Minnesota, USA). SpO~2~ was recorded after at least 2 min of stable SpO~2~ readings and a clear pulsatile photoplethysmographic signal. EBG sampling was conducted at rest after 10--20 min of inactivity by an experienced operator. Rubefacient cream (thurfyl nicotinate) was applied to the earlobe in order to obtain local vasodilation and was left for 10 min prior to sampling. The rubefacient was then removed and the earlobe was rubbed vigorously with a gauze swab. Using a No. 15 Swann Morton scalpel blade, an incision was made in the ear lobe approximately 3 mm from the lower tip of the pinna to a depth of approximately 3 mm or deep enough to ensure free, rapid blood flow. After discarding the initial drop, the sample was collected in a preheparinised plastic capillary tube, taking care to avoid the formation of air bubbles. Samples were discarded if they contained air bubbles or if blood flow was slow or showed signs of clotting. Samples were immediately analysed using an ABL90 Flex blood gas analyzer with CO-oximetry (Radiometer Medical ApS, Denmark). SaO~2~, pH, PaO~2~ and PaCO~2~ values were recorded.

Data analysed in this study were collected at the time as part of standard clinical care.

This research was done without patient involvement {#s2-1}
--------------------------------------------------

Patients were not invited to comment on the study design and were not consulted to develop patient relevant outcomes or interpret the results. Patients were not invited to contribute to the writing or editing of this document for readability or accuracy.

Power of the study and statistical analysis {#s2-2}
-------------------------------------------

Comparison of 36 SpO~2~ and 36 SaO~2~ measurements in the same patients would provide 80% power at the 5% significance level (two tails) to detect a difference of 2%[@R7] between mean SpO~2~ (92%)[@R20] and SaO~2~ (94%) with a SD=3% for both techniques. A Bland-Altman analysis was performed,[@R21] computing the mean difference SpO~2~ -- SaO~2~ ('bias') with the 95% limits of agreement (the interval of values within which 95% of the differences between SpO~2~ -- SaO~2~ lie) and the SD of these differences ('precision'). The expected bias between SpO~2~ and SaO~2~ according to most factures should be ≤2%, with precision of ≤4%.[@R7] Hypoxaemia was defined as a SaO~2~ measured by EBG CO-oximetry ≤93%. This cut-off has been associated with pathophysiological and clinical consequences in patients with SCD and chronic hypoxaemia.[@R22] In order to evaluate the accuracy of SpO~2~ to detect hypoxaemia, the sensitivity (the percentage of subjects with SpO~2~ ≤93% and SaO~2~ ≤93% of all subjects with an SaO~2~ ≤93%), specificity (the percentage of subjects with SpO~2~ \>93% and SaO~2~ \>93% of all subjects with an SaO~2~ \>93%), positive predictive value (the percentage of subjects with SaO~2~ ≤93% of all patients with SpO~2~ ≤93%) and negative predictive value (the percentage of subjects with SaO~2~ \>93% of all patients with SpO~2~ \>93%) were calculated. A p value \<0.05 was considered as statistically significant. Statistical analysis was performed with GraphPad Prism V.8.00 (GraphPad Software, California, USA).

Results {#s3}
=======

We analysed 39 simultaneous paired SaO~2~ and SpO~2~ readings from 33 children with SCD (boys 52%). Mean±SD age at the time of evaluation was 11.0±3.6 and distribution by ethnicity was 90% black African, 7% black Caribbean and 3% mixed Asian. Thirty-two participants were HbSS and one HbS/ß^+^. Almost half of the patients (48%, 16/33) were on hydroxyurea therapy and two patients were under chronic transfusion regime.

The mean±SD SaO~2~ was 94.3%±2.9% (range 87%--98%) and mean SpO~2~ was 93.6%±3.7% (range 83%--100%). A scatter plot of SaO~2~ versus SpO~2~ values from simultaneous records in each patient is represented in [figure 1](#F1){ref-type="fig"}. The bias between SpO~2~ and SaO~2~ measured by EBG with CO-oximetry was −0.7% and the precision 2.5% (95% limits of agreement from −5.4 to 4.1; [figure 2](#F2){ref-type="fig"}). In 23% of cases (n=*9*), difference SpO~2~− SaO~2~ was greater than expected bias of ±2%.[@R7] Of these, in three patients, oxygen saturation was overestimated by SpO~2~ and in six underestimated ([figure 2](#F2){ref-type="fig"}).

![Scatter plot of 39 simultaneous earlobe blood gas SaO~2~ and SpO~2~ records in 33 patient with sickle cell disease aged 5--18 years. There are some overlapping values. The blank circles with normal border represent one observation, the blank circles with bold border represent two observations, the black circles indicate three observations and the black square four observations.](bmjpo-2020-000690f01){#F1}

![Bland-Altman plot showing the average values of simultaneous SaO~2~ by earlobe blood gas and SpO~2~ for each measurement in patient with sickle cell disease (X-axis) versus the differences (Y-axis). Broken lines indicates mean difference (−0.7%) and limits of agreement (−5.4 to +4.1%; mean*±*2 SD). Shaded region represents a difference of ±2%, which is the accepted error range for SpO~2~. A total of 39 paired measurements were plotted but only 30 points are visible, as there are some overlapping values. The blank circles with normal border represent one observation, the blank circles with bold border represent two observations, the black circles indicate three observations and the black hexagon four observations.](bmjpo-2020-000690f02){#F2}

Thirteen participants (33%) were hypoxaemic (SaO~2~ ≤93% at EBG CO-oximetry), whereas a SpO~2~ ≤93% was found in 17 participants (43.5%). Among the 13 patients with SCD and SaO~2~ ≤93%, 12/13 (92%) had a partial pressure of oxygen (PaO~2~) \>70 mm Hg, indicating a right-shifted oxyhaemoglobin dissociation curve (normally, for a given SaO~2~ of 93%, a PaO~2~ of 70 mm Hg would be expected).

The sensitivity of pulse oximetry to detect hypoxaemia (using EBG CO-oximetry SaO~2~ as standard) was 100% (95% CIs 77% to 100%), specificity 85% (95% CI 66% to 94%), positive predictive value 76% (95% CI 53% to 90%) and negative predictive value 100% (95% CI 85% to 100%).

Discussion {#s4}
==========

We evaluated the accuracy of pulse oximetry in predicting oxygen saturation as measured by CO-oximetry on arterialised capillary blood from the earlobe. Although the bias (mean difference) between SpO~2~ and SaO~2~ was low (−0.7%), we found that pulse oximetry was less accurate than expected (error range within ±2% compared with SaO~2~) in almost a quarter (9/39) of measurements in ambulatory paediatric patients with SCD.

The accuracy of capillary blood gas compared with arterial gas analysis has been mainly evaluated by studies performed in the intensive care setting and their results have been compared in a meta-analysis showing that EBG may be appropriate as a replacement for arterial SaO~2~, unless precision is needed (adjusted r^2^=0.88; mean bias=3.8 mm Hg).[@R16] Interestingly from a clinical perspective, the meta-analysis showed that the accuracy of EBG in predicting arterial PaO~2~ improves in hypoxic conditions. Although there are no published data regarding the SCD population, the accuracy of EBG with CO-oximetry in this group is expected to be similar to that found in subjects without SCD.

Noticeably, the bias (−0.7%) and precision (2.5%) of SpO~2~versus SaO~2~ were lower than reported in previous studies comparing pulse oximetry and arterial blood gas with CO-oximetry in patients with SCD in both the acute[@R8] and outpatient[@R11] setting. Available evidence indicates conflicting data regarding the tendency of SpO~2~ to provide results higher or lower than SaO~2~ in the same patients, whereas in the present study SaO~2~ was more frequently underestimated (of at least 2%) than overestimated by SpO~2~ ([figure 2](#F2){ref-type="fig"}). Inaccuracy of pulse oximetry was more pronounced at lower SpO~2~ values ≤93%, consistently with previous findings in adult patients with ACS[@R9] and in outpatient children with SCD.[@R11] This finding suggests that an SpO~2~ ≤93% in a child with SCD should be confirmed through a SaO~2~ assessment. We suggest this can be preferably done through EBG with CO-oximetry, in order to limit pain and discomfort for the patient.

Pulse oximetry did not miss any case of hypoxaemia (SaO~2~ ≤93%), but it provided some false-positive results (specificity 85%) and its positive predictive value for hypoxaemia was only 76%, further indicating the need to evaluate SaO~2~ in patients with SCD with SpO~2~ values in the hypoxaemic range (SpO~2~ ≤93%). A former study that adopted the traditional definition of hypoxaemia based on PaO~2~ ≤70 mm Hg (corresponding to SaO~2~ ≤93% in a normal oxyhaemoglobin curve) found that none of nine patients with SCD and SpO~2~ ≤93% had a PaO~2~ ≤70 mm Hg. Similarly, in our study, only 1 out of 17 participants with SpO~2~ ≤93% had a PaO~2~ ≤70 mm Hg, indicating that the oxyhaemoglobin dissociation curve was right shifted, with a lower SaO~2~ for a given PaO~2~ compared with a normal curve.[@R24] In light of this evidence, we think that hypoxaemia in patients with SCD should be defined according to a SaO~2~ cut-off (as in the present study) rather than relying on PaO~2~ values, as SaO~2~ will better reflect the amount of oxygen that can be transported to the tissues (depending also on cardiac output, Hb concentration, etc).[@R27]

There are several factors that can contribute to unreliable pulse oximeter results in children with SCD. First, the oxyhaemoglobin dissociation curve tends to be right shifted when HbS polymerises.[@R28] Moreover, dysfunctional Hb (carboxyhaemoglobin and methaemoglobin) are elevated in the presence of intravascular haemolysis and, since they adsorb light at similar wavelengths as oxygenated and deoxygenated, can affect SpO~2~ readings of convectional pulse oximeters.[@R29] Furthermore, the high frequency of dark skin among patients with SCD can be an risk factor for poor accuracy of SpO~2~ in patients with hypoxaemia[@R30] and, finally, accuracy of SpO~2~ is lower at SaO~2~ values \<90%, a range of oxygen saturation often seen during ACS episodes.[@R9]

A strength of this study is that, to the best of the authors' knowledge, is the largest comparison of SpO~2~ and SaO~2~ values in patients with SCD published so far and the first to have been specifically powered for this outcome. Moreover, this is also the first report of EBG with CO-oximetry in patients with SCD.

There were also several limitations. Accuracy of pulse oximeter was evaluated only in comparison to EBG with CO-oximetry, without performing arterial blood gas with CO-oximetry, which represents the gold standard. However, the acceptable agreement demonstrated between CO-oximetry performed on EBG and arterial blood samples[@R16] should guarantee adequate reliability of the results. At this regards, we had a limited number of EBG SaO~2~ values \<90% (6/39, 15%). As known from the literature[@R30] and confirmed by our data ([figure 2](#F2){ref-type="fig"}), the accuracy of pulse oximetry is poorer at these low oxygen saturation levels. The inclusion of a higher number of patients with hypoxaemia with SCD, for example, enrolling inpatients with acute clinical manifestations that have more often low SaO~2~, would have probably negatively affected the overall agreement between SaO~2~ and SpO~2~. However, including acutely ill patients would have been beyond the scope of this study that aimed to compare the use of EBG and pulse oximetry in an outpatient, non-critical, setting.

Hb values were not recorded at the time of oxygen saturation measurement, precluding the possibility of evaluating the relationship between SpO~2~ -- SaO~2~ values and Hb concentration. The inclusion of patients with SCD with respiratory issues and the absence of individuals with acute comorbidity do not allow to extend the findings to the entire SCD population. Finally, due to the retrospective design, outcomes related to pain and acceptability of the EBG procedure in patients with SCD could not be evaluated.

Conclusions {#s5}
===========

Although the bias between SpO~2~ and SaO~2~ from arterialised earlobe gas analysis with CO-oximetry was rather small, pulse oximeter was inaccurate (differences at least ±2%) in almost a quarter of ambulatory paediatric patients with SCD, especially for SpO~2~ values≤93%. Clinician should be aware that when such low SpO~2~ values are detected in ambulatory patients with SCD, before taking major clinical decision based on these findings, they should be confirmed by an SaO~2~ assessment, due to the possibility of false-positive results. Evaluation of SaO~2~ in children with SCD can be performed, in alternative to traditional arterial blood sampling, through arterialised EBG with CO-oximetry that reduces pain and discomfort for the patient.[@R16]

Future studies should assess the agreement between pulse oximetry and arterialised EBG with CO-oximetry in patients with SCD acutely ill (ideally, also including the gold standard measure of SaO~2~ from arterial blood sampling), and whether the use of EBG in addition to SpO~2~ for evaluating oxygen saturation has any impact on clinical outcomes (length of hospitalisation, use of oxygen supplementation and requirement for non-invasive and invasive ventilation). Furthermore, it should be also evaluated if the use of EBG instead of arterial sampling for assessing oxygen saturation in acutely ill patients with SCD improves significantly the burden of pain and discomfort suffered during hospitalisation.
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